Bakterielle Meningitis und Neurotuberkulose

Die akute bakterielle Meningitis ist eine schwere akute Erkrankung, ca. 15% der Patienten versterben [1]. Im Gegensatz zur akuten bakteriellen Meningitis handelt es sich bei der tuberkulösen Meningitis um eine subakut verlaufende Erkrankung. Die Neurotuberkulose ist in Deutschland selten, aufgrund der hohen Komplikationsrate und der schlechten Prognose ist es aber umso wichtiger, diese Diagnose frühzeitig in Betracht zu ziehen.

• Literatur

• 1 Bijlsma MW, Brouwer MC, Kasanmoentalib ES. et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Dis 2016; 16: 339-347
• 2 Koelman DLH, van Kassel MN, Bijlsma MW. et al. Changing epidemiology of bacterial meningitis since introduction of conjugate vaccines: three decades of national meningitis surveillance in the Netherlands. Clin Infect Dis 2020;
• 3 Koelman DLH, Brouwer MC, van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect 2020; 26: 199-204
• 4 Völk S, Pfirrmann M, Koedel U. et al. Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic. J Neurol 2022; 269: 3389-3399
• 5 RKI. Epidemiologisches Bulletin. 2022
• 6 van de Beek D, Cabellos C, Dzupova O. et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; 22: S37-62
• 7 Dyckhoff-Shen S, Koedel U, Pfister HW. et al. SOP: emergency workup in patients with suspected acute bacterial meningitis. Neurol Res Pract 2021; 3: 2
• 8 Pfister H, Bühler R, Eiffert H. et al. Ambulant erworbene bakterielle Meningoeinzephalitis. Leitlinien für Diagnostik und Therapie in der Neurologie der DGN . 2016
• 9 Brouwer MC, McIntyre P, Prasad K. et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015; 9: CD004405
• 10 Charlier C, Perrodeau É, Leclercq A. et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis 2017; 17: 510-519
• 11 Figueiredo AHA, Brouwer MC, Bijlsma MW. et al. Community-acquired pneumonia in patients with bacterial meningitis: a prospective nationwide cohort study. Clin Microbiol Infect 2020; 26: 513 e517-513 e511
• 12 Wei TT, Hu ZD, Qin BD. et al. Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95: e3079
• 13 Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire FilmArray meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect 2020; 26: 281-290
• 14 Liesman RM, Strasburg AP, Heitman AK. et al. Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis. J Clin Microbiol 2018; 56
• 15 van de Beek D, Cabellos C, Dzupova O. et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; (Suppl. 03) 37-62
• 16 Lummel N, Koch M, Klein M. et al. Spectrum and prevalence of pathological intracranial magnetic resonance imaging findings in acute bacterial meningitis. Clin Neuroradiol 2016; 26: 159-167
• 17 Buchholz G, Koedel U, Pfister HW. et al. Dramatic reduction of mortality in pneumococcal meningitis. Crit Care 2016; 20: 312
• 18 Klein M, Koedel U, Pfefferkorn T. et al. Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care 2011; 15: R281
• 19 Glimaker M, Johansson B, Halldorsdottir H. et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS ONE 2014; 9: e91976
• 20 Deliran SS, Brouwer MC, Coutinho JM. et al. Bacterial meningitis complicated by cerebral venous thrombosis. Eur Stroke J 2020; 5: 394-401
• 21 Broom M, Best E, Heffernan H. et al. Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017. Infection 2022;
• 22 WHO. Global tuberculosis report 2021. 2021
• 23 Ducomble T, Tolksdorf K, Karagiannis I. et al. The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill 2013; 18: 20436
• 24 Cecchini D, Ambrosioni J, Brezzo C. et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 2009; 13: 269-271
• 25 Cresswell FV, Tugume L, Bahr NC. et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis 2020; 20: 308-317
• 26 Kohli M, Schiller I, Dendukuri N. et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2021; 1: Cd012768
• 27 Klein AMN, Pfister H-W. Tuberkulöse Meningitis. Therapie und Verlauf neurologischer Erkrankungen 2018; 7: 576-584
• 28 Yu J, Wang ZJ, Chen LH. et al. Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis 2016; 20: 494-499
• 29 Heemskerk AD, Bang ND, Thwaites GE. Therapy for tuberculous meningitis. N Engl J Med 2016; 374: 2188-2189
• 30 Thwaites G, Fisher M, Hemingway C. et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009; 59: 167-187
• 31 Thwaites GE, Schoeman JF. Update on tuberculosis of the central nervous system: pathogenesis, diagnosis, and treatment. Clin Chest Med 2009; 30: 745-754
• 32 Misra UK, Kumar M, Kalita J. Standard versus sequential anti-tubercular treatment in patients with tuberculous meningitis: a randomized controlled trial. Trans R Soc Trop Med Hyg 2021; 115: 94-102
• 33 Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2016; 4: CD002244
• 34 Heemskerk D, Farrar J, Caws M. Chapter 29: tuberculous meningitis. Infections of the central nervous system 2014; 4: 474-500
• 35 Schaberg T, Bauer T, Castell S. et al. Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2012; 66: 133-171
• 36 Suarez I, Gruell H, Heyckendorf J. et al. Intensified adjunctive corticosteroid therapy for CNS tuberculomas. Infection 2020; 48: 289-293
• 37 Misra UK, Kalita J, Sagar B. et al. Does adjunctive corticosteroid and aspirin therapy improve the outcome of tuberculous meningitis?. Neurol India 2018; 66: 1672-1677
• 38 Mai NT, Dobbs N, Phu NH. et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. Elife 2018; 7: e33478
• 39 Marais BJ, Cheong E, Fernando S. et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions. Open Forum Infect Dis 2021; 8: ofaa604